August 26, 2024
• Available for purchase today at Stelo.com for people in the U.S. 18 and older not using insulin
• Provides 24/7 powerful and personalized glucose insights directly to a smartphone, * revealing how food, exercise and sleep can affect glucose
• Tracking glucose just got easier, with no prescription and no fingersticks, ever
• Specifically designed to help people with Type 2 diabetes not using insulin and those with prediabetes reach their A1c goals and potentially slow the progression of diabetes.
SAN DIEGO–(BUSINESS WIRE)– DexCom , Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the U.S., is now available for purchase without a prescription at Stelo.com .
Stelo is a small biosensor worn on the back of the upper arm that leverages Dexcom’s most accurate glucose sensing technology. It is specifically designed to provide the 125 million Americans with Type 2 diabetes not using insulin and those with prediabetes with powerful, personalized glucose insights sent directly to a smartphone,* revealing how food, exercise and sleep can affect glucose – all without painful fingersticks. Read More >
